These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9095362)

  • 21. Stereoselective synthesis using immobilized Diels-Alderase ribozymes.
    Schlatterer JC; Stuhlmann F; Jäschke A
    Chembiochem; 2003 Oct; 4(10):1089-92. PubMed ID: 14523927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Intelligent' ribozyme whose activity is altered in response to K+ as a result of quadruplex formation.
    Nagata T; Sakurai Y; Hara Y; Mashima T; Kodaki T; Katahira M
    FEBS J; 2012 Apr; 279(8):1456-63. PubMed ID: 22339737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of hairpin ribozymes for in vitro and cellular applications.
    Yu Q; Burke JM
    Methods Mol Biol; 1997; 74():161-9. PubMed ID: 9204431
    [No Abstract]   [Full Text] [Related]  

  • 24. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes.
    Wang DY; Lai BH; Sen D
    J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro.
    Richardson MW; Hostalek L; Dobson M; Hu J; Shippy R; Siwkowski A; Marmur JD; Khalili K; Klotman PE; Hampel A; Rappaport J
    Methods Mol Biol; 2004; 252():339-58. PubMed ID: 15017062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hammerhead ribozymes: biochemical and chemical considerations.
    Goodchild J
    Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribozyme-catalyzed tRNA aminoacylation.
    Lee N; Bessho Y; Wei K; Szostak JW; Suga H
    Nat Struct Biol; 2000 Jan; 7(1):28-33. PubMed ID: 10625423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and biochemical characterization of DSL ribozyme.
    Horie S; Ikawa Y; Inoue T
    Biochem Biophys Res Commun; 2006 Jan; 339(1):115-21. PubMed ID: 16298344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kinetics and magnesium requirements for the folding of antigenomic delta ribozymes.
    Ananvoranich S; Perreault JP
    Biochem Biophys Res Commun; 2000 Apr; 270(2):600-7. PubMed ID: 10753670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative single-turnover kinetic analyses of trans-cleaving hammerhead ribozymes with naturally derived non-conserved sequence motifs.
    Weinberg MS; Rossi JJ
    FEBS Lett; 2005 Mar; 579(7):1619-24. PubMed ID: 15757651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concerted effects of two activator modules on the group I ribozyme reaction.
    Ikawa Y; Shiohara T; Ohuchi S; Inoue T
    J Biochem; 2009 Apr; 145(4):429-35. PubMed ID: 19122204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-catalytic replication of an RNA ligase ribozyme.
    Kim DE; Joyce GF
    Chem Biol; 2004 Nov; 11(11):1505-12. PubMed ID: 15556001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 2'-aminoalkyl-substituted fluorinated nucleobases and their influence on the kinetic properties of hammerhead ribozymes.
    Klöpffer AE; Engels JW
    Chembiochem; 2004 May; 5(5):707-16. PubMed ID: 15122643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand requirements for glmS ribozyme self-cleavage.
    McCarthy TJ; Plog MA; Floy SA; Jansen JA; Soukup JK; Soukup GA
    Chem Biol; 2005 Nov; 12(11):1221-6. PubMed ID: 16298301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of hybridizing arms in hammerhead ribozymes.
    Hendry P; McCall MJ; Lockett TJ
    Methods Mol Biol; 1997; 74():253-64. PubMed ID: 9204440
    [No Abstract]   [Full Text] [Related]  

  • 38. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
    Cole KB; Dorit RL
    J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.